Study summary · research use only
Mitochondrial uncoupler BAM15 ameliorates liver lipid metabolism disorders by activating the AMPK pathway
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
In this mouse study (high-fat-diet-induced obese mice), the authors examined BAM15, a mitochondrial uncoupler, compared with 2,4-Dinitrophenol (DNP) and carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP). BAM15 was reported to have higher binding capacity and stronger activity in mediating proton uncoupling than DNP and FCCP, and to promote mitochondrial fusion, division, autophagy, and the tricarboxylic acid cycle. The abstract reports that BAM15 was associated with improved hepatic lipid metabolism disorders through enhanced mitochondrial autophagy via activation of the AMPK (5'-AMP-activated protein kinase) pathway. The authors describe these findings as indicating potential relevance of BAM15 for liver lipid metabolism issues and as providing a theoretical basis for further research into lipid-related disease management.
Abstract
N5,N6-bis(2-Fluorophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine (BAM15) is a recently identified mitochondrial uncoupler with antitumor, anti-inflammatory, antioxidant and antiobesity properties. Although it has been shown that BAM15 has a high targeting ability to the liver, its capacity to improve liver metabolic disorders and the underlying mechanisms are not well understood. This study examined how BAM15 works in high-fat-diet (HFD) induced obese mice. Our results showed that compared with 2,4-Dinitrophenol (DNP) and carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), BAM15 has a higher binding capacity and stronger activity in mediating proton uncoupling, and effectively promoted mitochondrial fusion, division, autophagy, and the tricarboxylic acid cycle. BAM15 improved hepatic lipid metabolism disorders by enhancing mitochondrial autophagy through activation of the 5'-AMP-activated protein kinase (AMPK) pathway. This indicates that BAM15 could be used to treat liver lipid metabolism issues and offers a solid theoretical foundation for managing lipid-related diseases.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.